HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fang Xie Selected Research

cyclobenzaprine

7/2010Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysis.
5/2009Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: two randomized, double-blind, placebo-controlled studies of identical design.
1/2009Comparison of the single-dose pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg and cyclobenzaprine immediate-release 10 mg three times daily in the elderly: a randomized, open-label, crossover study.
1/2008Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10 mg three times daily in healthy young adults : a randomized, open-label, two-period crossover, single-centre study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fang Xie Research Topics

Disease

84Neoplasms (Cancer)
11/2022 - 02/2005
22Infections
01/2022 - 01/2009
17Pain (Aches)
09/2016 - 01/2007
14Inflammation (Inflammations)
01/2022 - 01/2010
13Breast Neoplasms (Breast Cancer)
12/2019 - 08/2011
12Breakthrough Pain
04/2012 - 01/2007
11Prostatic Neoplasms (Prostate Cancer)
01/2022 - 10/2014
11Cholangiocarcinoma
01/2018 - 04/2011
11Neoplasm Metastasis (Metastasis)
01/2018 - 02/2009
8Alzheimer Disease (Alzheimer's Disease)
10/2022 - 02/2007
8Hypersensitivity (Allergy)
03/2022 - 10/2008
8Carcinogenesis
09/2021 - 08/2011
7Pancreatic Neoplasms (Pancreatic Cancer)
10/2017 - 08/2011
7Carcinoma (Carcinomatosis)
01/2017 - 08/2011
7Pre-Eclampsia (Preeclampsia)
04/2014 - 05/2007
7Chronic Pain
01/2013 - 07/2007
6Cognitive Dysfunction
10/2022 - 01/2016
6Body Weight (Weight, Body)
02/2022 - 01/2012
6Wounds and Injuries (Trauma)
01/2022 - 08/2010
6Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 03/2015
5Cicatrix (Scar)
01/2022 - 08/2010
5Thyroid Nodule (Nodule, Thyroid)
01/2022 - 01/2020
5Melanoma (Melanoma, Malignant)
11/2018 - 08/2014
5Hyperalgesia
01/2016 - 10/2008
5Iron Overload
09/2013 - 08/2011
5Cancer Pain
04/2012 - 01/2007
4Papillary Thyroid Cancer
11/2022 - 12/2020
4Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 02/2007
4Glioma (Gliomas)
02/2022 - 02/2009
4Hypertrophic Cicatrix (Hypertrophic Scar)
01/2022 - 11/2020
4Adenocarcinoma
01/2020 - 05/2015
4Lymphatic Metastasis
01/2020 - 01/2012
4Neuroblastoma
01/2019 - 11/2017
4Spasm (Spasms)
07/2010 - 01/2008
3Neuroinflammatory Diseases
10/2022 - 01/2021
3Papillary Thyroid Microcarcinoma
02/2022 - 08/2019
3Sepsis (Septicemia)
02/2022 - 01/2009
3Hypertrophy
01/2022 - 09/2014
3Obesity
01/2022 - 01/2012
3COVID-19
01/2022 - 01/2020
3Bacterial Infections (Bacterial Infection)
01/2022 - 01/2017
3Ovarian Neoplasms (Ovarian Cancer)
11/2020 - 06/2016

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
08/2022 - 03/2011
19Pharmaceutical PreparationsIBA
01/2022 - 04/2007
18Biological ProductsIBA
03/2022 - 08/2007
14Opioid Analgesics (Opioids)IBA
09/2016 - 01/2007
13Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2010
13Fentanyl (Sublimaze)FDA LinkGeneric
06/2012 - 01/2007
13TabletsIBA
06/2012 - 01/2007
9Messenger RNA (mRNA)IBA
11/2020 - 02/2005
7CytokinesIBA
08/2022 - 04/2014
7Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 01/2017
7CopperIBA
12/2021 - 01/2017
6Reactive Oxygen Species (Oxygen Radicals)IBA
08/2022 - 09/2011
6Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2013
6MicroRNAs (MicroRNA)IBA
06/2020 - 08/2011
6GemcitabineFDA Link
01/2020 - 09/2011
5EnzymesIBA
08/2022 - 08/2008
5Therapeutic UsesIBA
01/2022 - 01/2018
5CollagenIBA
01/2022 - 02/2014
5Interleukin-6 (Interleukin 6)IBA
04/2021 - 11/2013
5Advanced Oxidation Protein Products (AOPP)IBA
01/2021 - 02/2014
5VaccinesIBA
01/2021 - 01/2014
5Peptides (Polypeptides)IBA
05/2020 - 04/2011
5LigandsIBA
01/2019 - 01/2010
4Amyloid (Amyloid Fibrils)IBA
10/2022 - 04/2011
4HomocysteineIBA
08/2022 - 01/2016
4Hormones (Hormone)IBA
02/2022 - 11/2017
41-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2022 - 07/2019
4AntibodiesIBA
01/2020 - 02/2009
4AcidsIBA
07/2019 - 12/2008
4Cisplatin (Platino)FDA LinkGeneric
01/2018 - 06/2016
4AntigensIBA
10/2017 - 02/2009
4Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2015 - 04/2012
4Melitten (Melittin)IBA
03/2013 - 10/2008
4cyclobenzaprineFDA LinkGeneric
07/2010 - 01/2008
3Contrast MediaIBA
11/2022 - 01/2016
3LipidsIBA
11/2022 - 05/2007
3Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2022 - 01/2020
3Parathyroid Hormone-Related ProteinIBA
01/2022 - 01/2013
3Polysaccharides (Glycans)IBA
01/2022 - 01/2020
3Interleukin-10 (Interleukin 10)IBA
01/2022 - 01/2017
3MicellesIBA
01/2022 - 04/2016
3NitratesIBA
12/2021 - 11/2018
3Morphine (MS Contin)FDA LinkGeneric
10/2021 - 06/2012
3GlucocorticoidsIBA
09/2021 - 01/2019
3Phosphotransferases (Kinase)IBA
03/2021 - 01/2014
3Long Noncoding RNAIBA
06/2020 - 12/2016
3Hyaluronic Acid (Hyaluronan)IBA
12/2019 - 05/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2019 - 08/2008
3Paclitaxel (Taxol)FDA LinkGeneric
11/2019 - 04/2016
3Estrogen ReceptorsIBA
07/2019 - 06/2013
3Radioisotopes (Radionuclides)IBA
01/2019 - 05/2011

Therapy/Procedure

32Therapeutics
08/2022 - 01/2007
10Drug Therapy (Chemotherapy)
01/2020 - 10/2011
9Radiofrequency Ablation
02/2022 - 01/2020
6Immunotherapy
08/2022 - 01/2015
4Aftercare (After-Treatment)
09/2019 - 02/2013
4Cardiopulmonary Resuscitation (CPR)
07/2015 - 08/2008
3Transplantation
01/2020 - 12/2013